Home / Technology & Devices (page 3)

Technology & Devices

Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has updated its approval of the company’s PD-L1 IHC 22C3 pharmDx assay. The assay can now be used as a companion diagnostic to identify a broader range of patients with stage III or metastatic …

Read More »

FDA Clears HemoSonics’ Quantra QPlus System, a Rapid Coagulation Diagnostic for Hospital Transfusion Management

Charlottesville, VA – March 13, 2019 – HemoSonics today announced that its innovative Quantra Hemostasis Analyzer platform, and its initial QPlus cartridge have been granted de novo marketing authorization by the FDA and are now available for sale in the United States. The fast and easy-to-use Quantra QPlus System provides novel and …

Read More »

Federal Agencies Charge 24 People in $1.2 Billion Medicare Telemedicine Fraud Scheme

One of the largest health care fraud schemes investigated by the FBI and the U.S. Department of Health and Human Services Office of the Inspector General (HHS-OIG) and prosecuted by the Department of Justice resulted in charges against 24 defendants, including the CEOs, COOs and others associated with five telemedicine …

Read More »

Foundation Medicine and Flatiron Publish Validation of Clinico-Genomic Database as a Platform to Advance Oncology Drug Development and Personalized Cancer Care

CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Foundation Medicine and Flatiron Health today announced the publication of study results in the Journal of the American Medical Association validating that real-world clinico-genomic data obtained during the course of routine patient care can yield scientifically and clinically meaningful insights. These insights can serve as real-world evidence …

Read More »

Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership in Prostate Cancer

SALT LAKE CITY, April 04, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that it has expanded its companion diagnostic collaboration with AstraZeneca and Merck (known as MSD outside the US and Canada).   Under the expanded collaboration, the companies will use BRACAnalysis CDx® to …

Read More »

Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. announced that data published online today in The Lancet Respiratory Medicine suggest that use of the company’s Envisia Genomic Classifier improves diagnosis for patients undergoing evaluation for interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF). The Envisia classifier is the first commercially available test that …

Read More »

Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics

INGELHEIM, Germany & BERLIN–(BUSINESS WIRE)–Boehringer Ingelheim today announced that it acquired ICD Therapeutics. The acquisition includes rights to ICD’s innovative MacroDel biologics-delivery platform. Boehringer Ingelheim will employ this platform for the development of novel therapeutics in collaboration with nanoPET Pharma GmbH, a former shareholder of ICD Therapeutics. Further details of …

Read More »

FDA Advances Landmark Policy Changes to Modernize Mammography Services and Improve their Quality

Today, the U.S. Food and Drug Administration announced important new steps to modernize breast cancer screening and help empower patients with more information when they are considering important decisions regarding their breast health care. For the first time in more than 20 years of regulating mammography facilities, the agency is …

Read More »

OSE Immunotherapeutics Enters Research Collaboration with Léon Bérard Cancer Center to Use Artificial Intelligence Technologies to Identify Novel Immuno-Oncology Targets

NANTES, France, March 26, 2019 (GLOBE NEWSWIRE) — OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE), announces a new research collaboration agreement with premier cancer research hospital, Léon Bérard Cancer Center in Lyon, France, to use artificial intelligence (AI)-based bioanalysis and bioinformatics to identify novel targets in immuno-oncology. Léon Bérard Cancer Center (CLB) has both …

Read More »

Ichor Medical Systems Enters Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform

SAN DIEGO–(BUSINESS WIRE)–Ichor® Medical Systems, Inc. (Ichor) announced today that it has entered into a collaboration and research license agreement with AstraZeneca (LSE, SSE, NYSE: AZN) for the development and clinical assessment of plasmid DNA constructs. The plasmids will encode monoclonal antibodies developed by AstraZeneca and will be delivered using Ichor’s TriGrid®Delivery System. …

Read More »